Pleura and Peritoneum (Jun 2024)

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

  • Foslund Ingrid Terese,
  • von Magius Sahra Aisha Vinholt,
  • Ainsworth Alan Patrick,
  • Detlefsen Sönke,
  • Fristrup Claus Wilki,
  • Knudsen Anja Oer,
  • Mortensen Michael Bau,
  • Tarpgaard Line Schmidt,
  • Jochumsen Kirsten Marie,
  • Graversen Martin

DOI
https://doi.org/10.1515/pp-2023-0049
Journal volume & issue
Vol. 9, no. 2
pp. 69 – 77

Abstract

Read online

There are few data on Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in women with primary unresectable or recurrent platinum-resistant peritoneal metastasis (PM) from ovarian cancer (OC). We evaluated survival, histological and cytological response, Quality of Life (QoL) and toxicity after PIPAC C/D in these patients.

Keywords